Clinical trials
Withdrawn Phase 1 Recurrence trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 3 |
| 2018 | 5 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| Beijing Boren Hospital | 2 |
| M.D. Anderson Cancer Center | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| AstraZeneca | 1 |
| Ayman H Qasrawi | 1 |
| BlueSphere Bio, Inc | 1 |
| CTI BioPharma | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Children's Oncology Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 36 |
| Lymphoma | 8 |
| Leukemia | 5 |
| Leukemia, Myeloid, Acute | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Burkitt Lymphoma | 4 |
| Neoplasms | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Dendritic Cell Sarcoma, Interdigitating | 3 |
| Lymphoma, Non-Hodgkin | 3 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.